Position
Chief Financial Officer
Company
Dyne Therapeutics
WalthamBiotechnologyHealth CareTherapeuticsDescription
Dyne Therapeutics, Inc has appointed Erick J Lucera as its new chief financial officer (CFO), effective March 31, 2025. Lucera’s extensive background in financial strategy and capital allocation is expected to play a critical role in the company’s upcoming late-stage clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD).
Quick answer
Dyne Therapeutics Appoints Erick J. Lucera as Chief Financial Officer (March 20, 2025). Dyne Therapeutics is based in Waltham, Massachusetts, United States.
- Who is the new Chief Financial Officer at Dyne Therapeutics?
- Dyne Therapeutics named Erick J. Lucera Chief Financial Officer, announced March 20, 2025.
- What did Dyne Therapeutics announce on March 20, 2025?
- Dyne Therapeutics, Inc has appointed Erick J Lucera as its new chief financial officer (CFO), effective March 31, 2025. Lucera’s extensive background in financial strategy and capital allocation is expected to play a critical role in the company’s upcoming late-stage clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD).
- What does Dyne Therapeutics do?
- Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
- Where is Dyne Therapeutics based?
- Dyne Therapeutics is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Nanoscope Therapeutics (March 20, 2025), Immuneering (March 20, 2025), Bristol Myers Squibb (March 20, 2025) and Hyku Biosciences (March 19, 2025) also announced leadership changes within 45 days of Dyne Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Nanoscope Therapeutics Appoints Ademola Daramola as Vice President, Quality and Compliance (March 20, 2025)
- Igor Matushansky, MD, PhD, Joins Immuneering as Chief Medical Officer (March 20, 2025)
- Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia and Gulf Countries (March 20, 2025)
- Hyku Biosciences Names Keith Wilcoxen as Chief Scientific Officer (March 19, 2025)
- Zenas BioPharma Appoints Lisa von Moltke, M.D. as Head of Research and Development and Chief Medical Officer (March 19, 2025)
- Exubrion Therapeutics Appoints Jennifer Kirk as Chief Executive Officer (March 18, 2025)
Who to call at Dyne Therapeutics, and when
A new leader at Dyne Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Dyne Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dyne Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dyne Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dyne Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Dyne Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.